Anna Gopin

Title: The Innovative Contributions of Anna Gopin

Introduction

Anna Gopin is a notable inventor based in Petach-Tikva, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of long-acting parenteral compositions. With a total of three patents to her name, Gopin's work focuses on improving treatment options for various mental health disorders.

Latest Patents

Among her latest patents, Gopin has developed depot systems comprising Cariprazine or its salts. These inventions provide long-acting pharmaceutical compositions that include a therapeutically effective amount of Cariprazine, suitable for administration at medically acceptable locations. The depot compositions are designed as in-situ implants for subcutaneous or intramuscular administration, offering prolonged release of the active ingredient and its metabolites for at least four weeks following a single administration. These compositions are particularly aimed at treating schizophrenia, major depressive disorder, and bipolar disorder.

Career Highlights

Gopin is currently associated with Mapi Pharma Ltd., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing treatment methodologies and improving patient outcomes in mental health care.

Collaborations

Some of her notable coworkers include Shai Rubnov and Ehud Marom, who contribute to her research and development efforts.

Conclusion

Anna Gopin's innovative work in the pharmaceutical industry highlights her commitment to enhancing treatment options for mental health disorders. Her patents reflect a significant advancement in the field, showcasing her expertise and dedication to improving patient care.